Table 2.
HR (95% CI) | p value | |
---|---|---|
baPWV (per 1 SD) | ||
Model 1 | 1.67 (1.44-1.93) | <0.001 |
Model 2 | 1.46 (1.23-1.73) | <0.001 |
Model 3 | 1.32 (1.09-1.59) | 0.005 |
Model 4 | 1.35 (1.11-1.64) | 0.003 |
Model 4 + maxIMT | 1.33 (1.09-1.62) | 0.004 |
maxIMT (per 1 SD) | ||
Model 1 | 1.46 (1.28-1.66) | <0.001 |
Model 2 | 1.29 (1.11-1.50) | 0.001 |
Model 3 | 1.22 (1.03-1.44) | 0.019 |
Model 4 | 1.22 (1.03-1.46) | 0.022 |
Model 4 + baPWV | 1.21 (1.01-1.44) | 0.036 |
Cox proportional hazards regression analyses unadjusted (Model 1) and adjusted for the following covariates:
Model 2, adjusted for gender and age.
Model 3, adjusted for gender and the other statistically significant variables in the unadjusted analyses (age, duration of diabetes, presence of hypertension at baseline, baseline systolic blood pressure, serum creatinine level, and Framingham risk score).
Model 4, adjusted for the conventional risk factors and baseline therapies (gender, age, smoking habit, BMI, HbA1c, duration of diabetes, systolic blood pressure, HDL cholesterol, LDL cholesterol, triglyceride, serum creatinine level, administration of anti-diabetic drugs, anti-hypertensive drugs, and anti-hyperlipidemic drugs).